Key Findings

The study characterizes four plasmid-mediated AmpC beta-lactamases (ACT-1, MIR-1, CMY-2, and CMY-1) and their kinetic properties, demonstrating that they confer resistance to beta-lactam antibiotics such as cephalosporins and penicillins.